
  
    
      
        Background_NNP
        The_DT retina_NN ,_, which_WDT is_VBZ exposed_VBN to_TO both_DT sunlight_NN and_CC very_RB
        high_JJ levels_NNS of_IN oxygen_NN ,_, is_VBZ exceptionally_RB rich_JJ in_IN
        polyunsaturated_JJ fatty_NN acids_NNS ,_, which_WDT makes_VBZ it_PRP a_DT favorable_JJ
        environment_NN for_IN the_DT generation_NN of_IN reactive_JJ oxygen_NN species_NNS ._.
        For_IN example_NN ,_, retinal_JJ pigment_NN epithelium_NN (_( RPE_NNP )_) generates_VBZ a_DT
        number_NN of_IN reactive_JJ oxygen_NN species_NNS when_WRB illuminated_JJ with_IN
        light_JJ [_NN 1_CD ]_NN ._. Furthermore_RB ,_, phagocytosis_NNS of_IN photoreceptor_NN
        outer_JJ segments_NNS by_IN RPE_NNP causes_NNS an_DT increase_NN in_IN intracellular_NN [_NN
        2_CD ]_NN and_CC extracellular_NN H_NNP 
        2_CD O_NNP 
        2_CD generation_NN [_NN 3_CD ]_NN ._. Oxidative_NNP stress_NN
        has_VBZ been_VBN suggested_VBN as_IN the_DT cause_NN of_IN a_DT number_NN of_IN retinal_JJ
        pathological_JJ conditions_NNS [_NN 4_CD 5_CD ]_NN ._.
        A_DT number_NN of_IN 
        in_IN vitro_NN studies_NNS have_VBP attempted_VBN to_TO
        characterize_VB the_DT effect_NN of_IN oxidative_JJ stress_NN on_IN RPE_NNP ._.
        Depending_VBG on_IN the_DT experimental_JJ conditions_NNS ,_, treatment_NN of_IN RPE_NNP
        with_IN H_NNP 
        2_CD O_NNP 
        2_CD can_MD cause_VB an_DT alteration_NN of_IN cellular_JJ
        functions_NNS [_NN 6_CD 7_CD ]_NN or_CC cell_NN death_NN [_NN 8_CD 9_CD ]_NN ._. Cytotoxic_NNP levels_NNS
        of_IN H_NNP 
        2_CD O_NNP 
        2_CD can_MD cause_VB significant_JJ mitochondrial_NN [_NN
        10_CD ]_NN and_CC genomic_JJ [_NN 11_CD ]_NN DNA_NNP damage_NN in_IN RPE_NNP simulating_VBG the_DT
        features_NNS of_IN programmed_VBN cell_NN death_NN [_NN 8_CD 12_CD ]_NN ._. Studies_NNPS from_IN
        other_JJ cell_NN types_NNS indicate_VBP that_IN early_JJ cellular_JJ events_NNS
        following_VBG H_NNP 
        2_CD O_NNP 
        2_CD treatment_NN include_VBP morphological_JJ
        alterations_NNS and_CC actin_NN re-organization_JJ [_NN 13_CD ]_NN ._. In_IN addition_NN ,_,
        activation_NN of_IN the_DT ERK_NNP (_( p_NN 42_CD /_NN 44_CD ,_, Extracellular_NNP
        signal-_NN Regulated_NNP Kinase_NNP )_) MAP_NNP kinases_NNS (_( Mitogen-_NNP Activated_NNP
        Protein_NNP kinases_NNS )_) can_MD occur_VB within_IN minutes_NNS following_VBG
        cellular_JJ oxidative_JJ stress_NN ._. Depending_VBG on_IN the_DT cell_NN type_NN
        examined_VBD ,_, inhibition_NN of_IN the_DT ERK_NNP activity_NN can_MD either_CC prevent_VB
        [_NN 14_CD ]_NN or_CC enhance_VB H_NNP 
        2_CD O_NNP 
        2_CD -_: induced_VBN cell_NN death_NN [_NN 15_CD ]_NN ._. The_DT
        involvement_NN of_IN actin_NN re-organization_JJ and_CC ERK_NNP activation_NN has_VBZ
        not_RB been_VBN examined_VBN in_IN RPE_NNP under_IN oxidative_JJ stress_NN ._.
        Lipid_NNP peroxidation_NN products_NNS ,_, such_JJ as_IN 4_CD -_: hydroxynonenal_NN
        (_( 4_CD -_: HNE_NNP )_) ,_, have_VBP attracted_VBN considerable_JJ attention_NN because_IN of_IN
        their_PRP$ potential_JJ involvement_NN in_IN aging_VBG and_CC in_IN a_DT number_NN of_IN
        neuropathological_JJ conditions_NNS [_NN 16_CD ]_NN ._. 4_CD -_: HNE_NNP was_VBD implicated_VBN
        in_IN the_DT etiology_NN of_IN some_DT pathological_JJ conditions_NNS in_IN the_DT eye_NN ._.
        For_IN example_NN ,_, levels_NNS of_IN 4_CD -_: HNE_NNP increased_VBN significantly_RB in_IN the_DT
        vitreous_JJ of_IN patients_NNS with_IN proliferative_JJ vitreoretinopathy_NN
        compared_VBN with_IN controls_NNS [_NN 17_CD ]_NN ._. Further_RB ,_, 4_CD -_: HNE_NNP forms_VBZ a_DT
        stable_JJ adduct_NN with_IN rhodopsin_NN in_IN the_DT photoreceptor_NN ,_, which_WDT
        may_MD interfere_VB with_IN its_PRP$ functions_NNS [_NN 18_CD ]_NN ._. 4_CD -_: HNE_NNP even_RB causes_VBZ
        cataracts_NNS in_IN cultured_JJ rat_NN lens_NN [_NN 19_CD 20_CD ]_NN ._. Whether_IN
        oxidative_JJ stress_NN on_IN RPE_NNP can_MD cause_VB accumulation_NN of_IN cellular_JJ
        HNE-protein_NNP adducts_NNS remains_VBZ unknown_JJ ._.
        Peroxisome_NNP proliferator-activated_JJ receptors_NNS (_( PPARs_NNP )_)
        belong_VB to_TO a_DT group_NN of_IN nuclear_JJ receptors_NNS that_WDT include_VBP
        steroid_NN ,_, retinoid_NN ,_, thyroid_NN hormone_NN receptors_NNS and_CC others_NNS [_NN
        21_CD 22_CD 23_CD ]_NN ._. There_EX are_VBP three_CD types_NNS of_IN PPARs_NNP :_: PPARα_NNP is_VBZ
        expressed_VBN predominantly_RB in_IN the_DT liver_NN ,_, heart_NN ,_, kidney_NN ,_, brown_JJ
        adipose_NN and_CC stomach_NN mucosa_NN ,_, and_CC is_VBZ important_JJ for_IN lipid_NN
        catabolism_NN ._. PPARγ_NNP is_VBZ found_VBN in_IN adipose_NN tissues_NNS and_CC is_VBZ
        important_JJ for_IN adipogenesis_NNS ._. PPARβ_NNP is_VBZ found_VBN in_IN most_JJS tissues_NNS ,_,
        but_CC its_PRP$ role_NN is_VBZ less_RBR well_RB defined_VBN ._. RPE_NNP cells_NNS express_VBP all_DT
        three_CD forms_NNS of_IN PPARs_NNP but_CC PPARβ_NNP is_VBZ the_DT dominant_JJ isoform_NN [_NN 24_CD
        ]_NN ._. There_EX is_VBZ a_DT 10_CD -_: fold_VB induction_NN of_IN PPARγ_NNP mRNA_NN that_WDT reaches_VBZ
        a_DT peak_NN at_IN 4_CD -_: hour_NN after_IN phagocytosis_NNS of_IN photoreceptor_NN outer_JJ
        segments_NNS ._. The_DT levels_NNS of_IN either_DT PPARα_NNP mRNA_NN or_CC PPARβ_NNP mRNA_NN are_VBP
        not_RB altered_VBN under_IN the_DT same_JJ conditions_NNS ._. Increases_NNS in_IN PPARγ_NNP
        in_IN RPE_NNP cells_NNS may_MD be_VB important_JJ for_IN handling_VBG the_DT lipids_NNS
        generated_VBN during_IN the_DT phagocytosis_NNS of_IN photoreceptor_NN outer_JJ
        segments_NNS [_NN 24_CD ]_NN ._. Since_IN RPE_NNP cells_NNS generate_VBP large_JJ amounts_NNS of_IN
        H_NNP 
        2_CD O_NNP 
        2_CD during_IN the_DT phagocytosis_NNS of_IN
        photoreceptor_NN outer_JJ segments_NNS ,_, there_EX is_VBZ a_DT possibility_NN that_DT
        activation_NN of_IN PPARγ_NNP may_MD assist_VB in_IN defending_VBG the_DT oxidative_JJ
        stress_NN associated_VBN with_IN phagocytosis_NNS ._.
        This_DT study_NN was_VBD designed_VBN to_TO examine_VB morphological_JJ
        alterations_NNS in_IN RPE_NNP during_IN oxidative_JJ stress_NN ,_, the_DT involvement_NN
        of_IN ERK_NNP MAP_NNP kinase_NN and_CC 4_CD -_: HNE_NNP and_CC to_TO test_VB the_DT hypothesis_NNS that_IN
        PPARγ_NNP activation_NN can_MD prevent_VB oxidative_JJ damage_NN on_IN RPE_NNP cells_NNS ._.
        The_DT human_JJ RPE_NNP cell_NN line_NN ,_, ARPE-_NNP 19_CD ,_, and_CC primary_JJ cultures_NNS of_IN
        adult_NN human_JJ RPE_NNP were_VBD used_VBN in_IN this_DT study_NN ._. ARPE-_NNP 19_CD is_VBZ a_DT
        spontaneous_JJ occurring_VBG ,_, non-transformed_JJ RPE_NNP cell_NN line_NN which_WDT
        expresses_VBZ RPE_NNP specific_JJ markers_NNS (_( such_JJ as_IN CRALBP_NNP and_CC RPE_NNP 65_CD )_)
        and_CC exhibits_VBZ morphological_JJ polarization_NN and_CC tight_JJ junctions_NNS
        similar_JJ to_TO native_JJ RPE_NNP [_NN 25_CD 26_CD ]_NN ._.
      
      
        Methods_NNP
        
          Materials_NNS
          WY_NNP 14643_CD ,_, 15_CD d-_NN PGJ_NNP 
          2_CD ,_, azelaoyl_NN PAF_NNP and_CC ciglitazone_NN were_VBD
          purchased_VBN from_IN Cayman_NNP (_( Ann_NNP Arbor_NNP ,_, MI_NNP )_) ._. LY_NNP 171883_CD was_VBD
          purchased_VBN from_IN Alexis_NNP Biochemicals_NNP (_( San_NNP Diego_NNP ,_, CA_NNP )_) ._. AG_NNP 126_CD
          and_CC PD_NNP 98059_CD were_VBD purchased_VBN from_IN Calbiochem_NNP (_( San_NNP Diego_NNP ,_,
          CA_NNP )_) ._. Hydrogen_NNP peroxide_NN and_CC other_JJ pharmacological_JJ and_CC
          general_JJ biochemical_JJ reagents_NNS were_VBD purchased_VBN from_IN Sigma_NNP
          (_( St_NNP ._. Louis_NNP ,_, MO_NNP )_) unless_IN otherwise_RB stated_VBN ._.
        
        
          Cell_NNP cultures_NNS
          
          ARPE-_NNP 19_CD cells_NNS [_NN 25_CD ]_NN were_VBD obtained_VBN
          from_IN the_DT American_NNP Type_NNP Culture_NNP Collection_NNP and_CC grown_VBN in_IN
          DMEM_NNP /_NN F_NN 12_CD containing_VBG 10_CD %_NN heat-inactivated_JJ fetal_JJ bovine_JJ
          serum_NN and_CC 2_CD ._. 5_CD mM_NN glutamine_NN ._. 
          Human_NNP primary_JJ RPE_NNP cultures_NNS were_VBD
          established_VBN from_IN donor_NN eyes_NNS obtained_VBN from_IN the_DT Arkansas_NNP
          Lions_NNP Eye_NNP Bank_NNP &_CC Laboratory_NNP ._. The_DT globe_NN was_VBD sectioned_JJ
          at_IN the_DT ora_NN serrata_NN ,_, and_CC the_DT lens_NN and_CC vitreous_JJ body_NN were_VBD
          removed_VBN ._. The_DT eye_NN cup_NN was_VBD then_RB filled_VBN with_IN 4_CD %_NN dispase_NN
          (_( prepared_VBN in_IN DMEM_NNP )_) containing_VBG 1_CD ×_NN antibiotic-antimycotic_JJ
          reagents_NNS (_( final_JJ concentrations_NNS :_: 100_CD units_NNS /_NN ml_NN Penicillin_NNP
          G_NNP ,_, 100_CD μg_NN /_NN ml_NN Streptomycin_NNP and_CC 0_CD ._. 25_CD μg_NN /_NN ml_NN Amphotericin_NNP B_NNP )_)
          and_CC incubated_JJ in_IN a_DT 37_CD °_NN C_NNP incubator_NN with_IN 5_CD %_NN CO_NNP 
          2_CD for_IN ~_NN 30_CD minutes_NNS ._. RPE_NNP cells_NNS were_VBD then_RB
          removed_VBN under_IN a_DT dissecting_VBG microscope_NN ,_, dissociated_JJ by_IN
          trituration_NN using_VBG a_DT Pasteur_NNP pipette_NN ,_, and_CC then_RB plated_JJ on_IN
          poly-_NN L-_NNP lysine_NN (_( 25_CD mg_NN /_NN liter_NN in_IN water_NN )_) coated_JJ 35_CD -_: cm_NN
          2_CD culture_NN dishes_NNS ._. The_DT cell_NN population_NN was_VBD then_RB expanded_VBN by_IN
          sequentially_RB subculturing_VBG into_IN 25_CD -_: cm_NN 2_CD tissue_NN culture_NN
          flasks_NNS ,_, then_IN to_TO 75_CD -_: cm_NN 2_CD tissue_NN culture_NN flasks_NNS ._. Cells_NNP of_IN
          passages_NNS #_# 3_CD -_: #_# 6_CD were_VBD used_VBN for_IN this_DT study_NN ._. The_DT culture_NN
          medium_NN consisted_VBD of_IN 10_CD %_NN heat-inactivated_JJ fetal_JJ bovine_JJ
          serum_NN ,_, 2_CD ._. 5_CD mM_NN glutamine_NN and_CC 1_CD ×_NN antibiotic-antimycotic_JJ
          reagents_NNS in_IN DMEM_NNP ._.
        
        
          Cell_NNP viability_NN
          Cells_NNP were_VBD plated_JJ in_IN 96_CD -_: well_RB plates_NNS (_( human_JJ primary_JJ
          RPE_NNP :_: 10_CD ,_, 000_CD cells_NNS /_NN well_RB ,_, ARPE-_NNP 19_CD :_: 15_CD ,_, 000_CD -_: 20_CD ,_, 000_CD
          cells_NNS /_NN well_RB ,_, unless_IN otherwise_RB stated_VBN )_) overnight_JJ ,_, fed_VBN with_IN
          serum-free_JJ medium_NN or_CC treated_VBN with_IN testing_NN agents_NNS
          (_( prepared_VBN in_IN serum-free_JJ medium_NN )_) the_DT next_JJ day_NN followed_VBN by_IN
          H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN for_IN a_DT day_NN ,_, then_RB the_DT
          viability_NN from_IN each_DT treatment_NN was_VBD determined_VBN by_IN the_DT MTT_NNP
          (_( 3_CD -_: (_( 4_CD ,_, 5_CD -_: dimethylthiazol-_NN 2_CD -_: yl_NN )_) -_: 2_CD ,_, 5_CD -_: diphenyltetrazolium_NN
          bromide_NN )_) assay_NN [_NN 27_CD ]_NN ._. Culture_NNP medium_NN was_VBD removed_VBN after_IN
          treatment_NN and_CC then_RB 100_CD μl_NN MTT_NNP solution_NN (_( 100_CD μg_NN /_NN ml_NN
          prepared_VBN in_IN DMEM_NNP )_) was_VBD added_VBN to_TO each_DT well_RB ._. The_DT cultures_NNS
          were_VBD incubated_JJ at_IN 37_CD °_NN C_NNP for_IN one_CD hour_NN in_IN a_DT tissue_NN culture_NN
          incubator_NN ._. The_DT MTT_NNP solution_NN was_VBD then_RB removed_VBN and_CC the_DT
          cells_NNS in_IN each_DT well_RB were_VBD lysed_JJ by_IN the_DT addition_NN of_IN 100_CD μl_NN
          dimethyl_NN sulfoxide_NN ._. The_DT plate_NN was_VBD placed_VBN on_IN a_DT shaker_NN for_IN
          one_CD hour_NN at_IN room_NN temperature_NN to_TO complete_VB the_DT lysing_VBG
          process_NN ,_, then_RB the_DT optical_JJ density_NN of_IN each_DT well_RB was_VBD
          measured_VBN by_IN a_DT 96_CD -_: well_RB plate_NN reader_NN with_IN a_DT filter_NN setting_VBG
          at_IN 570_CD nm_NN (_( reference_NN filter_NN setting_VBG was_VBD 630_CD nm_NN )_) ._. When_WRB a_DT
          pharmacological_JJ agent_NN was_VBD used_VBN in_IN the_DT experiment_NN ,_, the_DT MTT_NNP
          reading_NN from_IN cultures_NNS treated_VBN with_IN that_DT agent_NN alone_RB was_VBD
          used_VBN as_IN 100_CD %_NN cellular_JJ viability_NN ._.
        
        
          Actin_NNP staining_VBG
          This_DT was_VBD performed_VBN as_IN described_VBN by_IN Carter_NNP et_CC al_NN ._. [_NN 28_CD
          ]_NN ._. Cells_NNP grown_VBN on_IN coverslips_NNS were_VBD treated_VBN with_IN H_NNP 
          2_CD O_NNP 
          2_CD for_IN various_JJ period_NN of_IN time_NN as_IN
          indicated_VBN in_IN figure_NN legends_NNS ,_, washed_VBD three_CD times_NNS with_IN
          phosphate-buffered_JJ saline_NN (_( PBS_NNP )_) ,_, then_RB fixed_VBN for_IN 10_CD
          minutes_NNS with_IN 3_CD ._. 7_CD %_NN formaldehyde_NN (_( prepared_VBN in_IN PBS_NNP )_) ._. The_DT
          cultures_NNS were_VBD then_RB washed_VBN three_CD times_NNS with_IN PBS_NNP ,_, extracted_VBN
          with_IN -_: 20_CD °_NN C_NNP acetone_NN for_IN 5_CD minutes_NNS followed_VBN by_IN three_CD washes_NNS
          with_IN PBS_NNP ._. Each_DT culture_NN was_VBD then_RB stained_JJ with_IN Texas_NNP
          Red-phalloidin_NNP (_( Molecular_NNP Probes_NNP ,_, Eugene_NNP ,_, OR_NNP )_) prepared_VBN in_IN
          PBS_NNP containing_VBG 1_CD %_NN bovine_JJ serum_NN albumin_NN for_IN 20_CD minutes_NNS at_IN
          room_NN temperature_NN in_IN a_DT lightproof_NN box_NN ._. The_DT cultures_NNS were_VBD
          then_RB washed_VBN three_CD times_NNS with_IN water_NN ,_, mounted_VBD with_IN
          GEL_NNP /_NN MOUNT_NNP (_( Biomedia_NNP ,_, Foster_NNP City_NNP ,_, CA_NNP )_) ._. The_DT slides_NNS were_VBD
          examined_VBN under_IN a_DT Nikon_NNP microscope_NN Eclipse_NNP E_NNP 600_CD (_( Nikon_NNP
          Instruments_NNP Inc_NNP ._. ,_, Melville_NNP ,_, NY_NNP )_) ._. Cells_NNP were_VBD photographed_VBN
          digitally_RB at_IN a_DT fixed_VBN exposure_NN time_NN by_IN using_VBG a_DT
          Photometrics_NNP CoolSNAP_NNP fx_NN camera_NN (_( Roper_NNP Scientific_NNP ,_, Inc_NNP ._. ,_,
          Tucson_NNP ,_, AZ_NNP )_) and_CC the_DT software_NN MetaVue_NNP ,_, Meta_NNP Imaging_NNP Series_NNP
          4_CD ._. 5_CD (_( Universal_NNP Imaging_NNP Corporation_NNP ,_, Downingtown_NNP ,_, PA_NNP )_) ._.
        
        
          Immunohistochemical_NNP and_CC immunofluorescent_NN
          staining_VBG
          Cultures_NNP grown_VBN on_IN coverslips_NNS were_VBD used_VBN in_IN this_DT set_JJ of_IN
          experiments_NNS ._. Phospho-_NNP ERK_NNP was_VBD detected_VBN by_IN mouse_NN
          anti-phospho-_JJ ERK_NNP antibody_NN (_( Santa_NNP Cruz_NNP Biotechnology_NNP ,_,
          Santa_NNP Cruz_NNP ,_, CA_NNP ,_, used_VBN at_IN 1_CD :_: 1500_CD )_) and_CC the_DT Vectastain_NNP ABC_NNP
          kit_NN (_( Vector_NNP Lab_NNP ._. ,_, Burlingame_NNP ,_, CA_NNP )_) with_IN diaminobenzidine_NN
          as_IN the_DT chromogen_NN ._. Cellular_NNP 4_CD -_: HNE_NNP protein_NN adducts_NNS were_VBD
          detected_VBN by_IN rabbit_NN anti-_NN 4_CD -_: HNE_NNP antibodies_NNS (_( Calbiochem_NNP ,_, San_NNP
          Diego_NNP ,_, CA_NNP ,_, used_VBN at_IN 1_CD :_: 250_CD )_) followed_VBN by_IN anti-rabbit_JJ
          secondary_JJ antibody_NN labeled_VBN with_IN FITC_NNP (_( Dako_NNP Corporation_NNP ,_,
          Carpinteria_NNP ,_, CA_NNP )_) ._. The_DT cultures_NNS were_VBD then_RB mounted_VBN with_IN
          GEL_NNP /_NN MOUNT_NNP ._. The_DT slides_NNS were_VBD examined_VBN under_IN Nikon_NNP
          microscope_NN Eclipse_NNP E_NNP 600_CD (_( Nikon_NNP Instruments_NNP Inc_NNP ._. ,_,
          Melville_NNP ,_, NY_NNP )_) ._. Cells_NNP were_VBD photographed_VBN at_IN fixed_VBN exposure_NN
          time_NN with_IN Nikon_NNP digital_JJ still_RB camera_NN DXM_NNP 1200_CD (_( Nikon_NNP
          Instruments_NNP Inc_NNP ._. ,_, Melville_NNP ,_, NY_NNP )_) and_CC the_DT software_NN Nikon_NNP
          ACT-_NNP 1_CD version_NN 2_CD ._. 11_CD (_( Nikon_NNP Corporation_NNP ,_, Tokyo_NNP ,_, Japan_NNP )_) ._.
        
        
          Nuclear_NNP staining_VBG
          Cells_NNP grown_VBN on_IN coverslips_NNS were_VBD treated_VBN with_IN H_NNP 
          2_CD O_NNP 
          2_CD for_IN various_JJ periods_NNS of_IN time_NN as_IN
          indicated_VBN in_IN figure_NN legends_NNS ,_, fixed_VBN for_IN 10_CD minutes_NNS with_IN
          3_CD ._. 7_CD %_NN formaldehyde_NN (_( prepared_VBN in_IN PBS_NNP )_) ,_, stained_JJ with_IN 1_CD μg_NN /_NN ml_NN
          bisbenzimide_NN solution_NN (_( Hoechst_NNP 33258_CD ,_, Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_,
          MO_NNP )_) for_IN 10_CD minutes_NNS at_IN room_NN temperature_NN ,_, mounted_VBD with_IN
          GEL_NNP /_NN MOUNT_NNP ,_, then_RB observed_VBD under_IN a_DT fluorescent_NN microscope_NN
          as_IN described_VBN in_IN the_DT previous_JJ section_NN ._.
        
        
          Western_JJ blot_NN analysis_NN
          RPE_NNP cells_NNS were_VBD plated_JJ in_IN T-_NNP 150_CD flasks_NNS overnight_JJ ,_, fed_VBN
          with_IN serum-free_JJ medium_NN for_IN a_DT day_NN ,_, then_RB treated_VBN with_IN H_NNP 
          2_CD O_NNP 
          2_CD as_IN indicated_VBN in_IN figure_NN legends_NNS ._. For_IN
          sample_NN preparation_NN ,_, cultures_NNS were_VBD detached_VBN with_IN a_DT scraper_NN
          in_IN PBS_NNP then_RB centrifuged_JJ ._. The_DT cell_NN pellets_NNS were_VBD suspended_VBN
          in_IN 150_CD -_: 300_CD μl_NN ice-cold_JJ RIPA_NNP lysis_NNS buffer_NN (_( 1_CD %_NN NP-_NNP 40_CD ,_, 0_CD ._. 5_CD %_NN
          Na-deoxycholate_NNP ,_, 0_CD ._. 1_CD %_NN SDS_NNP in_IN PBS_NNP ,_, 0_CD ._. 5_CD mM_NN
          Phenylmethylsulfonyl_NNP fluoride_NN (_( PMSF_NNP )_) ,_, 0_CD ._. 02_CD mg_NN /_NN ml_NN
          Aprotinin_NNP ,_, 1_CD mM_NN Na_NNP 
          3_CD VO_NNP 
          4_LS )_) and_CC incubated_JJ for_IN 30_CD min_NN on_IN ice_NN ._.
          Each_DT sample_NN was_VBD further_JJ homogenized_JJ by_IN passage_NN through_IN a_DT
          21_CD -_: gauge_VB needle_NN followed_VBN by_IN an_DT addition_NN of_IN 10_CD μl_NN PMSF_NNP
          (_( stock_NN solution_NN :_: 50_CD mM_NN )_) ._. The_DT samples_NNS were_VBD then_RB incubated_JJ
          for_IN 30_CD min_NN on_IN ice_NN and_CC subsequently_RB centrifuged_JJ at_IN 14_CD ,_, 000_CD
          RPM_NNP for_IN 20_CD min_NN at_IN 4_CD °_NN C_NNP ._. The_DT supernatant_NN from_IN each_DT sample_NN
          was_VBD collected_VBN and_CC an_DT aliquot_NN was_VBD taken_VBN for_IN protein_NN
          concentration_NN determination_NN by_IN Micro_NNP BCA_NNP Protein_NNP Assay_NNP
          Reagent_NNP Kit_NNP (_( Pierce_NNP ,_, Rockford_NNP ,_, IL_NNP )_) ._. Protein_NNP samples_NNS were_VBD
          stored_VBN at_IN -_: 70_CD °_NN C_NNP until_IN ready_JJ for_IN electrophoretic_JJ analysis_NN ._.
          Equal_NNP amounts_NNS of_IN protein_NN samples_NNS (_( 20_CD μg_NN /_NN well_RB )_) were_VBD heated_JJ
          at_IN 95_CD °_NN C_NNP for_IN 6_CD min_NN then_RB loaded_VBD onto_IN 1_CD %_NN SDS_NNP ,_, 10_CD %_NN
          polyacrylamide_NN gels_NNS ._. BenchMark_NNP pre-stained_JJ protein_NN ladder_NN
          (_( Invitrogen_NNP life_NN technologies_NNS ,_, Carlsbad_NNP ,_, California_NNP )_) was_VBD
          used_VBN as_IN molecular_JJ weight_NN standards_NNS ._. Following_VBG
          electrophoretic_JJ separation_NN ,_, the_DT proteins_NNS were_VBD transferred_VBN
          to_TO nitrocellulose_NN membranes_NNS ._. Equal_NNP loading_NN and_CC
          appropriate_JJ transfer_NN of_IN each_DT lane_NN was_VBD confirmed_VBN by_IN
          staining_VBG the_DT membrane_NN with_IN the_DT Ponceau_NNP S_NNP solution_NN (_( Sigma_NNP ,_,
          St_NNP ._. Louis_NNP ,_, MO_NNP )_) ._. Membranes_NNP were_VBD blocked_VBN in_IN 5_CD %_NN nonfat_JJ dried_VBD
          milk_NN for_IN one_CD hour_NN ,_, washed_VBN in_IN 10_CD mM_NN Tris-buffered_NNP saline_NN
          (_( pH_NN 7_CD ._. 5_LS )_) containing_VBG 0_CD ._. 1_CD %_NN Tween-_NNP 20_CD (_( TBST_NNP )_) and_CC probed_JJ with_IN
          primary_JJ antibody_NN overnight_JJ at_IN 4_CD °_NN C_NNP ._. Membranes_NNP were_VBD washed_VBN
          with_IN TBST_NNP and_CC then_RB incubated_JJ for_IN 1_CD hour_NN at_IN room_NN
          temperature_NN with_IN a_DT secondary_JJ antibody_NN followed_VBN by_IN washing_VBG
          three_CD times_NNS with_IN TBST_NNP ,_, immersed_VBN in_IN ECL_NNP Plus_NNP western_JJ
          blotting_VBG detection_NN system_NN (_( Amersham_NNP Pharmacia_NNP Biotech_NNP ,_,
          Buckinghamshire_NNP ,_, England_NNP )_) for_IN 1_CD min_NN and_CC then_RB exposed_VBN to_TO
          Kodak_NNP X-_NNP ray_NN film_NN (_( Rochester_NNP ,_, NY_NNP )_) ._. The_DT films_NNS were_VBD analyzed_VBN
          by_IN densitometry_NN using_VBG a_DT ChemiImager_NNP 5500_CD imaging_NN system_NN
          with_IN AlphaEaseFC_NNP software_NN (_( Alpha_NNP Innotech_NNP Corporation_NNP ,_,
          San_NNP Leandro_NNP ,_, CA_NNP )_) ._. Results_NNS ,_, expressed_VBD as_IN percentage_NN of_IN
          control_NN ,_, from_IN replicate_VB experiments_NNS were_VBD pooled_VBN and_CC
          averaged_VBN ._. The_DT primary_JJ antibodies_NNS used_VBN in_IN this_DT set_JJ of_IN
          experiments_NNS were_VBD from_IN Santa_NNP Cruz_NNP (_( anti-_NN ERK_NNP 1_CD /_NN 2_CD ,_, used_VBN at_IN
          1_CD :_: 5000_CD ;_: anti-phospho-_JJ ERK_NNP ,_, used_VBN at_IN 1_CD :_: 1000_CD ;_: anti-_NN PPARγ_NNP ,_,
          used_VBN at_IN 1_CD :_: 2000_CD )_) or_CC from_IN Calbiochem_NNP (_( anti-_NN 4_CD -_: HNE_NNP ,_, used_VBN at_IN
          1_CD :_: 2_CD ,_, 000_CD )_) ._.
        
        
          Statistical_NNP analysis_NN
          Unless_IN otherwise_RB stated_VBN ,_, results_NNS of_IN cell_NN viability_NN
          experiments_NNS were_VBD pooled_VBN from_IN 12_CD replicate_VB samples_NNS derived_VBN
          from_IN 3_CD independent_JJ experiments_NNS ,_, and_CC expressed_VBD as_IN mean_NN ±_NN
          SEM_NNP ._. Statistical_NNP analyses_NNS were_VBD performed_VBN by_IN analysis_NN of_IN
          variance_NN (_( one-way_JJ ANOVA_NNP )_) followed_VBN by_IN the_DT Bonferroni_NNP test_NN
          to_TO determine_VB the_DT significance_NN of_IN difference_NN ._.
        
      
      
        Results_NNS
        
          Cytotoxicity_NNP of_IN H_NNP 2_CD O_NNP 2_CD toward_IN primary_JJ human_JJ RPE_NNP and_CC
          ARPE-_NNP 19_CD cells_NNS
          Initial_JJ experiments_NNS analyzing_VBG the_DT cytotoxic_JJ effect_NN of_IN
          oxidative_JJ stress_NN on_IN primary_JJ cultures_NNS of_IN human_JJ RPE_NNP cells_NNS
          indicated_VBD that_IN H_NNP 
          2_CD O_NNP 
          2_CD at_IN 1_CD mM_NN or_CC less_JJR did_VBD not_RB affect_VB
          cellular_JJ viability_NN ._. Higher_JJR concentrations_NNS caused_VBD a_DT sharp_JJ
          decrease_NN of_IN viability_NN in_IN human_JJ RPE_NNP such_JJ that_IN a_DT 24_CD -_: hour_NN
          treatment_NN of_IN cells_NNS with_IN 1_CD ._. 2_CD mM_NN H_NNP 
          2_CD O_NNP 
          2_CD lowered_VBD the_DT viability_NN to_TO 13_CD %_NN of_IN
          controls_NNS (_( Fig_NNP ._. 1_LS A_DT ,_, squares_NNS )_) ._. This_DT concentration_NN lowered_VBD
          the_DT viability_NN of_IN human_JJ RPE_NNP to_TO 62_CD %_NN after_IN a_DT 4_CD -_: hour_NN
          treatment_NN (_( Fig_NNP ._. 1_LS A_DT ,_, circles_NNS )_) ._.
          In_IN a_DT set_NN of_IN analogous_JJ experiments_NNS ,_, ARPE-_NNP 19_CD cells_NNS
          treated_VBN with_IN various_JJ concentrations_NNS of_IN H_NNP 
          2_CD O_NNP 
          2_CD for_IN 4_CD hours_NNS or_CC 24_CD hours_NNS showed_VBD that_IN
          a_DT 4_CD -_: hour_NN treatment_NN with_IN 1_CD mM_NN H_NNP 
          2_CD O_NNP 
          2_CD did_VBD not_RB affect_VB viability_NN ._. An_DT
          increase_NN of_IN H_NNP 
          2_CD O_NNP 
          2_CD concentrations_NNS beyond_IN 1_CD mM_NN decreased_VBD
          viability_NN such_JJ as_IN 2_CD mM_NN H_NNP 
          2_CD O_NNP 
          2_CD decreased_VBD the_DT viability_NN to_TO 46_CD %_NN of_IN
          controls_NNS in_IN 4_CD hours_NNS (_( Fig_NNP ._. 1_LS B_NNP ,_, circles_VBZ )_) ._. Treatment_NNP of_IN
          cells_NNS with_IN H_NNP 
          2_CD O_NNP 
          2_CD for_IN 24_CD hours_NNS caused_VBD a_DT dose-dependent_JJ
          decrease_NN of_IN viability_NN with_IN a_DT LD_NNP 
          50_CD of_IN ~_NN 1_CD ._. 35_CD mM_NN (_( Fig_NNP ._. 1_LS B_NNP ,_, squares_NNS )_) ._.
          H_NNP 
          2_CD O_NNP 
          2_CD induced_VBN cytotoxicity_NN in_IN RPE_NNP cells_NNS
          appears_VBZ to_TO be_VB affected_VBN by_IN the_DT density_NN of_IN cells_NNS in_IN
          cultures_NNS [_NN 29_CD ]_NN ._. To_TO study_VB this_DT phenomenon_NN ,_, ARPE-_NNP 19_CD cells_NNS
          plated_JJ in_IN 96_CD -_: well_RB plates_NNS with_IN densities_NNS of_IN 10_CD ,_, 000_CD ,_, 20_CD ,_, 000_CD
          or_CC 40_CD ,_, 000_CD cells_NNS /_NN well_RB were_VBD subjected_VBN to_TO H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN ._. Cells_NNP grown_VBN in_IN a_DT
          high-density_JJ culture_NN were_VBD indeed_RB more_RBR resistant_JJ to_TO H_NNP 
          2_CD O_NNP 
          2_CD as_IN compared_VBN to_TO those_DT grown_VBN in_IN a_DT
          low-density_NN culture_NN (_( Fig_NNP ._. 1_LS C_NNP )_) ._. For_IN example_NN ,_, H_NNP 
          2_CD O_NNP 
          2_CD at_IN 1_CD ._. 4_CD mM_NN reduced_VBD cellular_JJ viability_NN
          to_TO 11_CD %_NN ,_, 49_CD %_NN or_CC 94_CD %_NN of_IN control_NN in_IN cultures_NNS with_IN 10_CD ,_, 000_CD ,_,
          20_CD ,_, 000_CD or_CC 40_CD ,_, 000_CD cells_NNS /_NN well_RB ,_, respectively_RB ._.
        
        
          H_NNP 2_CD O_NNP 2_CD induced_VBN morphological_JJ alterations_NNS and_CC
          formation_NN of_IN 4_CD -_: HNE-adducts_NNP
          To_TO analyze_VB morphological_JJ changes_NNS of_IN RPE_NNP cells_NNS treated_VBN
          with_IN a_DT cytotoxic_JJ concentration_NN of_IN H_NNP 
          2_CD O_NNP 
          2_CD ,_, ARPE-_NNP 19_CD cells_NNS were_VBD treated_VBN with_IN
          1_CD ._. 5_CD mM_NN H_NNP 
          2_CD O_NNP 
          2_CD for_IN various_JJ periods_NNS of_IN time_NN and_CC then_RB
          processed_VBN for_IN actin_NN staining_VBG ._. Without_IN H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN ,_, stress_NN fibers_NNS appeared_VBD
          thin_JJ and_CC diffuse_NN in_IN control_NN cells_NNS (_( Fig_NNP ._. 2_LS A_DT ,_, arrow_NN )_) ._. At_IN
          15_CD -_: min_NN after_IN treatment_NN ,_, these_DT cells_NNS appeared_VBD to_TO round_VB up_RP
          and_CC significant_JJ ruffling_VBG occurred_VBN at_IN the_DT edge_NN of_IN their_PRP$
          plasma_NN membrane_NN (_( Fig_NNP ._. 2_LS B_NNP ,_, arrows_NNS )_) ._. Overall_RB thickening_VBG of_IN
          stress_NN fibers_NNS occurred_VBD at_IN two_CD hours_NNS after_IN treatment_NN in_IN
          addition_NN to_TO the_DT membrane_NN ruffling_VBG (_( Fig_NNP ._. 2_LS C_NNP ,_, arrows_NNS )_) ._.
          Additional_JJ morphological_JJ changes_NNS after_IN 4_CD hours_NNS of_IN H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN (_( Fig_NNP ._. 2_LS D_NNP ,_, 2_CD E_NNP ,_, 2_CD F_NN )_) included_VBD
          distinctive_JJ dense_JJ bands_NNS at_IN the_DT periphery_NN of_IN some_DT cells_NNS
          (_( Fig_NNP ._. 2_LS D_NNP ,_, arrows_NNS )_) ,_, peri-nuclear_JJ staining_VBG of_IN actin_NN fibers_NNS
          in_IN other_JJ cells_NNS (_( which_WDT made_VBD the_DT nuclei_NN prominent_JJ ,_, Fig_NNP ._. 2_LS E_NNP ,_,
          arrows_NNS )_) and_CC microspikes_NNS (_( Fig_NNP ._. 2_LS F_NN ,_, arrow_NN )_) on_IN the_DT cell_NN
          surface_NN of_IN some_DT cells_NNS ._.
          Subsequent_JJ experiments_NNS with_IN immunofluorescent_NN staining_VBG
          indicated_VBN that_IN 1_CD ._. 5_CD mM_NN H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN of_IN ARPE-_NNP 19_CD cells_NNS for_IN 4_CD
          hours_NNS led_VBN to_TO the_DT formation_NN of_IN 4_CD -_: HNE_NNP protein_NN adducts_NNS both_DT
          in_IN the_DT cytoplasm_NN and_CC nucleus_NN ,_, presumably_RB as_IN a_DT result_NN of_IN
          lipid-peroxidation_JJ (_( Fig_NNP ._. 3_LS A_DT ,_, 3_CD B_NNP )_) ._. Various_JJ protein_NN bands_NNS on_IN
          Western_JJ blots_NNS were_VBD positive_JJ for_IN anti-_NN HNE_NNP antibody_NN
          reactivity_NN ,_, further_RBR intensified_VBN as_IN a_DT result_NN of_IN H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN (_( Fig_NNP 3_CD C_NNP )_) ._. Densitometry_NNP
          measurements_NNS were_VBD performed_VBN to_TO estimate_VB the_DT collective_JJ
          increase_NN of_IN band_NN intensity_NN in_IN each_DT lane_NN between_IN 39_CD Kd_NNP and_CC
          87_CD Kd_NNP ._. Results_NNS derived_VBN from_IN a_DT total_NN of_IN six_CD independent_JJ
          experiments_NNS indicated_VBD that_DT treatment_NN of_IN cells_NNS with_IN 0_CD ._. 5_CD ,_,
          1_CD ,_, 1_CD ._. 5_CD or_CC 2_CD mM_NN H_NNP 
          2_CD O_NNP 
          2_CD caused_VBD an_DT increase_NN of_IN intensity_NN to_TO
          2_CD ._. 5_CD -_: ,_, 3_CD ._. 1_CD -_: ,_, 3_CD ._. 7_CD -_: or_CC 7_CD ._. 1_CD -_: fold_VB of_IN control_NN ,_,
          respectively_RB ._.
          Though_IN there_EX was_VBD significant_JJ cytoskeletal_NN alterations_NNS
          and_CC lipid_NN peroxidation_NN at_IN 4_CD hours_NNS after_IN H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN ,_, nuclear_JJ staining_VBG using_VBG
          bisbenzimide_NN (_( Hoechst_NNP 33258_CD )_) indicated_VBD that_IN most_JJS cells_NNS
          maintained_VBD normal_JJ nuclear_JJ morphology_NN at_IN this_DT time_NN (_( Fig_NNP ._.
          4_LS A_DT ,_, untreated_JJ cells_NNS ;_: Fig_NNP ._. 4_LS B_NNP ,_, 4_CD hours_NNS after_IN treatment_NN )_) ._.
          Nuclear_JJ condensation_NN increased_VBD with_IN length_NN of_IN H_NNP 
          2_CD O_NNP 
          2_CD exposure_NN ,_, which_WDT was_VBD clearly_RB evident_JJ
          at_IN 12_CD hours_NNS after_IN H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN (_( Fig_NNP 4_CD C_NNP ,_, arrows_NNS )_) ,_, and_CC even_RB
          more_RBR prominent_JJ at_IN 16_CD hours_NNS after_IN treatment_NN (_( Fig_NNP ._. 4_LS D_NNP )_) ._.
          These_DT results_NNS suggest_VBP that_IN H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN caused_VBD apoptosis_NNS in_IN RPE_NNP ._.
          Nuclear_JJ condensation_NN appeared_VBD to_TO start_VB at_IN the_DT edge_NN of_IN the_DT
          culture_NN (_( relatively_RB lower_JJR density_NN area_NN ,_, Fig_NNP ._. 4_LS C_NNP ,_, arrows_NNS )_)
          and_CC spread_NN to_TO the_DT center_NN part_NN of_IN the_DT culture_NN (_( higher_JJR
          density_NN ,_, Fig_NNP ._. 4_LS D_NNP )_) over_IN time_NN ._. This_DT phenomenon_NN is_VBZ
          consistent_JJ with_IN the_DT viability_NN assay_NN in_IN which_WDT higher_JJR
          density_NN cultures_NNS were_VBD more_RBR resistant_JJ to_TO oxidative_JJ stress_NN
          (_( Fig_NNP ._. 1_LS C_NNP )_) ._.
        
        
          Effect_NN of_IN oxidative_JJ stress_NN on_IN PPARγ_NNP protein_NN
          expression_NN
          During_IN rod_NN outer_JJ segment_NN ingestion_NN ,_, there_EX is_VBZ a_DT
          generation_NN of_IN H_NNP 
          2_CD O_NNP 
          2_CD [_NN 2_CD 3_CD ]_NN and_CC an_DT up-regulation_JJ of_IN
          PPARγ_NNP mRNA_NN expression_NN [_NN 24_CD ]_NN in_IN RPE_NNP ,_, experiments_NNS were_VBD
          performed_VBN to_TO determine_VB if_IN H_NNP 
          2_CD O_NNP 
          2_CD could_MD induce_VB PPARγ_NNP protein_NN
          expression_NN over_IN the_DT control_NN levels_NNS ._. ARPE-_NNP 19_CD cells_NNS were_VBD
          treated_VBN with_IN various_JJ concentrations_NNS (_( 0_CD ._. 5_LS ,_, 1_CD ,_, 1_CD ._. 5_CD ,_, 2_CD mM_NN )_)
          of_IN H_NNP 
          2_CD O_NNP 
          2_CD for_IN 24_CD hours_NNS and_CC processed_VBN for_IN
          Western_JJ blot_NN analysis_NN ._. Results_NNS indicated_VBD a_DT slight_JJ
          induction_NN of_IN PPARγ_NNP protein_NN levels_NNS in_IN some_DT experiments_NNS ._.
          This_DT induction_NN ,_, however_RB ,_, was_VBD not_RB apparent_JJ in_IN other_JJ
          experiments_NNS (_( Results_NNS not_RB shown_VBN )_) ._. Densitometry_NNP analyses_NNS
          from_IN a_DT total_NN of_IN six_CD independent_JJ experiments_NNS indicated_VBD
          that_DT treatment_NN of_IN these_DT cells_NNS with_IN 0_CD ._. 5_CD ,_, 1_CD ,_, 1_CD ._. 5_CD or_CC 2_CD mM_NN H_NNP 
          2_CD O_NNP 
          2_CD for_IN 24_CD hours_NNS caused_VBD an_DT alteration_NN of_IN
          band_NN intensity_NN to_TO 76_CD %_NN ,_, 108_CD %_NN ,_, 113_CD %_NN or_CC 104_CD %_NN of_IN controls_NNS ,_,
          respectively_RB ._. There_EX was_VBD no_DT significant_JJ change_NN of_IN PPARγ_NNP
          protein_NN level_NN after_IN 30_CD -_: min_NN or_CC 12_CD -_: hour_NN H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN ,_, either_CC (_( results_NNS not_RB
          shown_VBN )_) ._. A_DT separate_JJ set_NN of_IN experiments_NNS also_RB indicated_VBD that_DT
          treatment_NN of_IN primary_JJ human_JJ RPE_NNP cells_NNS with_IN 1_CD mM_NN H_NNP 
          2_CD O_NNP 
          2_CD for_IN 24_CD hours_NNS did_VBD not_RB induce_VB PPARγ_NNP
          protein_NN expression_NN over_IN the_DT control_NN levels_NNS (_( results_NNS not_RB
          shown_VBN )_) ._.
        
        
          Prevention_NNP of_IN oxidative_JJ stress_NN induced_VBD cytotoxicity_NN
          by_IN PPARγ_NNP agonists_NNS
          Even_RB though_IN H_NNP 
          2_CD O_NNP 
          2_CD did_VBD not_RB increase_VB PPARγ_NNP protein_NN
          expression_NN significantly_RB as_IN indicated_VBN in_IN the_DT previous_JJ
          study_NN ,_, experiments_NNS were_VBD performed_VBN to_TO determine_VB whether_IN
          PPARγ_NNP agonists_NNS could_MD activate_VBP the_DT existing_VBG PPARγ_NNP thus_RB
          preventing_VBG H_NNP 
          2_CD O_NNP 
          2_CD induced_VBN cytotoxicity_NN in_IN RPE_NNP cells_NNS ._.
          Cells_NNP were_VBD pretreated_JJ with_IN the_DT PPARγ_NNP agonist_NN 15_CD d-_NN PGJ_NNP 
          2_CD overnight_RB followed_VBN by_IN H_NNP 
          2_CD O_NNP 
          2_CD for_IN one_CD day_NN (_( without_IN 15_CD d-_NN PGJ_NNP 
          2_LS )_) and_CC processed_VBN for_IN the_DT MTT_NNP
          viability_NN assay_NN ._. Results_NNS indicated_VBD that_IN 15_CD d-_NN PGJ_NNP 
          2_CD prevented_VBN H_NNP 
          2_CD O_NNP 
          2_CD induced_VBN cytotoxicity_NN in_IN primary_JJ
          human_JJ RPE_NNP cultures_NNS in_IN a_DT dose-dependent_JJ manner_NN (_( Fig_NNP ._. 5_LS A_DT )_) ._.
          Subsequent_JJ experiments_NNS with_IN ARPE-_NNP 19_CD cells_NNS also_RB indicated_VBD
          this_DT saving_VBG effect_NN ._. While_IN H_NNP 
          2_CD O_NNP 
          2_CD at_IN 1_CD ._. 3_CD mM_NN ,_, 1_CD ._. 4_CD mM_NN or_CC 1_CD ._. 5_CD mM_NN lowered_VBD
          the_DT ARPE-_NNP 19_CD viability_NN to_TO 64_CD %_NN ,_, 46_CD %_NN or_CC 28_CD %_NN of_IN control_NN ,_,
          respectively_RB ;_: pretreatment_NN of_IN these_DT cells_NNS with_IN 1_CD μM_NN
          15_CD d-_NN PGJ_NNP 
          2_CD raised_VBD the_DT viabilities_NNS to_TO 95_CD %_NN ,_, 84_CD %_NN
          or_CC 68_CD %_NN of_IN control_NN ,_, respectively_RB (_( Fig_NNP ._. 5_LS B_NNP )_) ._. Cells_NNP stained_JJ
          with_IN Hoechst_NNP 33258_CD indicated_VBD that_IN 15_CD d-_NN PGJ_NNP 
          2_CD prevented_VBN H_NNP 
          2_CD O_NNP 
          2_CD induced_VBN nuclear_JJ condensation_NN (_( Fig_NNP ._.
          4_LS E_NNP ;_: compare_VB this_DT with_IN Fig_NNP ._. 4_LS D_NNP )_) ._. The_DT other_JJ PPARγ_NNP agonists_NNS ,_,
          ciglitazone_NN [_NN 30_CD ]_NN ,_, azelaoyl_NN PAF_NNP [_NN 31_CD ]_NN and_CC LY_NNP 171883_CD [_NN
          32_CD ]_NN ,_, however_RB ,_, were_VBD not_RB effective_JJ (_( tested_VBN between_IN 1_CD -_: 10_CD
          μM_NN ,_, 3_CD independent_JJ experiments_NNS for_IN each_DT agent_NN ,_, results_NNS not_RB
          shown_VBN )_) ._. The_DT PPARα_NNP agonist_NN WY_NNP 14643_CD had_VBD some_DT saving_VBG effect_NN
          at_IN a_DT high_JJ concentration_NN (_( 40_CD μM_NN )_) ,_, however_RB ,_, the_DT difference_NN
          was_VBD not_RB statistically_RB significant_JJ (_( results_NNS not_RB
          shown_VBN )_) ._.
        
        
          Activation_NNP of_IN ERK_NNP by_IN H_NNP 2_CD O_NNP 2_CD
          A_DT set_NN of_IN experiments_NNS was_VBD performed_VBN to_TO determine_VB the_DT
          effects_NNS of_IN H_NNP 
          2_CD O_NNP 
          2_CD on_IN ERK_NNP activation_NN ._. ARPE-_NNP 19_CD cells_NNS
          were_VBD treated_VBN with_IN 1_CD ._. 5_CD mM_NN H_NNP 
          2_CD O_NNP 
          2_CD for_IN 1_CD hour_NN and_CC processed_VBN for_IN
          immunohistochemical_JJ staining_VBG using_VBG antibodies_NNS against_IN
          phospho-_NN ERK_NNP ._. Untreated_NNP cells_NNS showed_VBD a_DT faint_JJ phospho-_NN ERK_NNP
          staining_VBG while_IN there_EX was_VBD an_DT apparent_JJ increase_NN of_IN
          phospho-_NN ERK_NNP staining_VBG in_IN the_DT cytoplasm_NN and_CC nuclei_NN in_IN H_NNP 
          2_CD O_NNP 
          2_CD treated_VBN cells_NNS (_( Fig_NNP ._. 6_CD A_DT ,_, 6_CD B_NNP )_) ._. A_DT
          separate_JJ set_NN of_IN cultures_NNS was_VBD treated_VBN with_IN H_NNP 
          2_CD O_NNP 
          2_CD for_IN 30_CD min_NN and_CC then_RB processed_VBN for_IN
          Western_JJ blot_NN analysis_NN ._. This_DT H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN of_IN the_DT cells_NNS caused_VBN only_RB a_DT
          slight_JJ alteration_NN in_IN ERK_NNP levels_NNS but_CC led_VBN to_TO a_DT
          dose-dependent_JJ increase_NN of_IN phospho-_NN ERK_NNP ,_, with_IN a_DT maximal_NN
          stimulation_NN observed_VBD at_IN 1_CD ._. 5_CD mM_NN (_( Fig_NNP ._. 6_CD C_NNP )_) ._. Densitometry_NNP
          analyses_NNS from_IN 3_CD independent_JJ experiments_NNS indicated_VBD that_IN
          0_CD ._. 5_CD ,_, 1_CD ,_, 1_CD ._. 5_CD or_CC 2_CD mM_NN H_NNP 
          2_CD O_NNP 
          2_CD caused_VBD an_DT increase_NN of_IN p_NN 42_CD ERK_NNP (_( ERK_NNP 2_LS )_)
          phosphorylation_NN to_TO 2_CD ._. 1_CD -_: ,_, 12_CD ._. 7_CD -_: ,_, 18_CD ._. 8_CD -_: or_CC 2_CD ._. 0_CD -_: fold_VB of_IN
          control_NN ,_, respectively_RB ._. Similar_JJ treatment_NN caused_VBD an_DT
          increase_NN of_IN p_NN 44_CD ERK_NNP (_( ERK_NNP 1_LS )_) phosphorylation_NN to_TO 1_CD ._. 5_CD -_: ,_,
          15_CD ._. 7_CD -_: ,_, 21_CD ._. 4_LS -_: or_CC 3_CD ._. 4_CD -_: fold_VB of_IN control_NN ,_, respectively_RB ._. The_DT
          phospho-_NN ERK_NNP in_IN H_NNP 
          2_CD O_NNP 
          2_CD treated_VBN samples_NNS remained_VBD higher_JJR than_IN
          control_NN at_IN 24_CD -_: hour_NN after_IN treatment_NN (_( results_NNS not_RB
          shown_VBN )_) ._.
        
        
          Effect_NN of_IN ERK_NNP inhibition_NN on_IN H_NNP 2_CD O_NNP 2_CD induced_VBN
          cytotoxicity_NN in_IN ARPE-_NNP 19_CD
          Since_IN ERK_NNP activation_NN appeared_VBD to_TO be_VB an_DT early_JJ event_NN
          associated_VBN with_IN H_NNP 
          2_CD O_NNP 
          2_CD induced_VBN cytotoxicity_NN ,_, experiments_NNS
          were_VBD performed_VBN to_TO determine_VB if_IN inhibitors_NNS of_IN ERK_NNP
          activation_NN could_MD affect_VB the_DT cytotoxicity_NN caused_VBN by_IN H_NNP 
          2_CD O_NNP 
          2_CD ._. ARPE-_NNP 19_CD cells_NNS were_VBD pretreated_JJ with_IN
          10_CD μM_NN PD_NNP 98059_CD (_( a_DT MEK_NNP inhibitor_NN which_WDT functions_NNS upstream_RB
          of_IN ERK_NNP [_NN 33_CD ]_NN )_) followed_VBN by_IN H_NNP 
          2_CD O_NNP 
          2_CD challenge_NN ._. Results_NNS from_IN 3_CD
          independent_JJ experiments_NNS indicated_VBD that_IN this_DT agent_NN could_MD
          prevent_VB low-dose_JJ (_( 1_CD -_: 1_CD ._. 2_LS mM_NN )_) H_NNP 
          2_CD O_NNP 
          2_CD induced_VBN cell_NN death_NN slightly_RB ._. In_IN
          contrast_NN ,_, it_PRP enhanced_VBD high-dose_JJ (_( 1_CD ._. 3_LS -_: 1_CD ._. 6_CD mM_NN )_) H_NNP 
          2_CD O_NNP 
          2_CD induced_VBN cell_NN death_NN ._. These_DT effects_NNS in_IN
          either_DT case_NN were_VBD not_RB remarkable_JJ (_( results_NNS not_RB shown_VBN )_) ._. This_DT
          agent_NN at_IN concentrations_NNS higher_JJR than_IN 10_CD μM_NN was_VBD toxic_JJ to_TO
          ARPE-_NNP 19_CD cells_NNS by_IN itself_PRP and_CC could_MD enhance_VB H_NNP 
          2_CD O_NNP 
          2_CD toxicity_NN (_( results_NNS not_RB shown_VBN )_) ._.
          In_IN a_DT separate_JJ set_NN of_IN experiments_NNS ,_, ARPE-_NNP 19_CD cells_NNS were_VBD
          pretreated_JJ with_IN 10_CD μM_NN AG_NNP 126_CD (_( a_DT protein_NN tyrosine_NN kinase_NN
          inhibitor_NN [_NN 34_CD ]_NN )_) followed_VBN by_IN H_NNP 
          2_CD O_NNP 
          2_CD challenge_NN ._. The_DT treatment_NN of_IN cells_NNS
          with_IN 1_CD ._. 3_CD mM_NN ,_, 1_CD ._. 4_CD mM_NN or_CC 1_CD ._. 5_CD mM_NN H_NNP 
          2_CD O_NNP 
          2_CD decreased_VBD the_DT cellular_JJ viability_NN to_TO
          66_CD %_NN ,_, 40_CD %_NN or_CC 22_CD %_NN of_IN control_NN ,_, respectively_RB ._. Pretreatment_NNP of_IN
          cells_NNS with_IN AG_NNP 126_CD raised_VBD the_DT viability_NN to_TO 72_CD %_NN (_( p_NN <_NN 0_CD ._. 05_CD
          compared_VBN to_TO H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN only_RB )_) ,_, 63_CD %_NN (_( p_NN <_NN 0_CD ._. 005_CD )_)
          or_CC 35_CD %_NN (_( p_NN <_NN 0_CD ._. 01_CD )_) of_IN control_NN ,_, respectively_RB ._. AG_NNP 126_CD at_IN
          concentrations_NNS higher_JJR than_IN 10_CD μM_NN was_VBD toxic_JJ to_TO ARPE-_NNP 19_CD
          cells_NNS by_IN itself_PRP and_CC could_MD enhance_VB H_NNP 
          2_CD O_NNP 
          2_CD toxicity_NN (_( results_NNS not_RB shown_VBN )_) ._.
          Both_DT AG_NNP 126_CD (_( 10_CD μM_NN )_) and_CC 15_CD d-_NN PGJ_NNP 
          2_CD (_( 1_CD μM_NN )_) could_MD prevent_VB H_NNP 
          2_CD O_NNP 
          2_CD induced_VBN cytotoxicity_NN in_IN ARPE-_NNP 19_CD ,_, a_DT
          set_NN of_IN experiments_NNS was_VBD also_RB performed_VBN to_TO determine_VB
          whether_IN these_DT two_CD agents_NNS had_VBD additive_JJ saving_NN effects_NNS ._.
          While_IN 1_CD ._. 4_CD mM_NN H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN reduced_VBD the_DT viability_NN to_TO
          ~_NN 40_CD %_NN of_IN control_NN ,_, AG_NNP 126_CD raised_VBD this_DT viability_NN to_TO ~_NN 55_CD %_NN of_IN
          control_NN and_CC 15_CD d-_NN PGJ_NNP 
          2_CD raised_VBD the_DT viability_NN to_TO 75_CD %_NN of_IN
          control_NN ._. A_DT combination_NN of_IN these_DT two_CD agents_NNS did_VBD not_RB raise_VB
          the_DT viability_NN above_IN 15_CD d-_NN PGJ_NNP 
          2_CD alone_RB (_( Fig_NNP ._. 7_CD )_) ._.
        
      
      
        Discussion_NNP
        
          Cytotoxicity_NNP of_IN oxidative_JJ stress_NN on_IN RPE_NNP
          Results_NNS from_IN this_DT study_NN indicated_VBD that_IN both_DT primary_JJ
          human_JJ RPE_NNP cultures_NNS and_CC ARPE-_NNP 19_CD cells_NNS were_VBD susceptible_JJ to_TO
          H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN ._. It_PRP is_VBZ important_JJ to_TO point_VB
          out_IN that_IN H_NNP 
          2_CD O_NNP 
          2_CD showed_VBD a_DT very_RB steep_JJ dose-response_JJ
          curve_NN in_IN primary_JJ RPE_NNP cultures_NNS under_IN our_PRP$ experimental_JJ
          conditions_NNS such_JJ that_IN an_DT increase_NN of_IN H_NNP 
          2_CD O_NNP 
          2_CD concentration_NN from_IN 1_CD mM_NN to_TO 1_CD ._. 2_CD mM_NN
          for_IN one-day_JJ treatment_NN caused_VBD a_DT decrease_NN in_IN viability_NN from_IN
          ~_NN 100_CD %_NN to_TO ~_NN 10_CD %_NN of_IN control_NN (_( Fig_NNP ._. 1_LS A_DT )_) ._. Though_IN the_DT H_NNP 
          2_CD O_NNP 
          2_CD titration_NN curve_NN in_IN ARPE-_NNP 19_CD was_VBD not_RB
          as_RB steep_JJ as_IN observed_VBN in_IN primary_JJ RPE_NNP ,_, one-day_JJ treatment_NN of_IN
          these_DT cells_NNS with_IN 1_CD ._. 8_CD mM_NN H_NNP 
          2_CD O_NNP 
          2_CD could_MD decrease_VB the_DT cellular_JJ
          viability_NN to_TO ~_NN 10_CD %_NN of_IN control_NN while_IN 1_CD mM_NN H_NNP 
          2_CD O_NNP 
          2_CD did_VBD not_RB affect_VB cellular_JJ viability_NN
          (_( Fig_NNP ._. 1_LS B_NNP )_) ._. The_DT sharp_JJ dose-response_JJ curves_NNS demonstrated_VBN in_IN
          this_DT study_NN suggests_VBZ that_IN it_PRP is_VBZ important_JJ to_TO have_VB an_DT
          effective_JJ cellular_JJ anti-oxidation_JJ mechanism_NN to_TO prevent_VB
          the_DT build-up_NN of_IN oxidative_JJ stress_NN over_IN a_DT critical_JJ level_NN ._.
          An_DT increase_NN of_IN oxidative_JJ stress_NN in_IN RPE_NNP is_VBZ associated_VBN with_IN
          an_DT increase_NN of_IN cellular_JJ catalase_NN ,_, metallothionein_NN [_NN 3_CD ]_NN
          and_CC glutathione_NN S-_NNP transferase_NN [_NN 35_CD ]_NN ,_, which_WDT should_MD serve_VB
          as_IN a_DT protective_JJ mechanism_NN to_TO decrease_VB the_DT cytotoxicity_NN
          caused_VBN by_IN H_NNP 
          2_CD O_NNP 
          2_CD and_CC other_JJ reactive_JJ oxygen_NN species_NNS ._.
          This_DT protective_JJ mechanism_NN declines_NNS with_IN age_NN because_IN a_DT
          study_NN analyzing_VBG metallothionein_NN levels_NNS in_IN RPE_NNP of_IN macular_NN
          region_NN showed_VBD a_DT dramatic_JJ decrease_NN in_IN aged_VBN donors_NNS (_( mean_VB
          age_NN =_SYM 80_CD -_: yr_NN )_) as_IN compared_VBN to_TO those_DT from_IN younger_JJR donors_NNS
          (_( mean_VB age_NN =_SYM 58_CD -_: yr_NN )_) [_NN 36_CD ]_NN ._. A_DT separate_JJ report_NN concluded_VBD
          that_IN there_EX was_VBD also_RB an_DT age-dependent_JJ decrease_NN of_IN catalase_NN
          activity_NN in_IN RPE_NNP [_NN 37_CD ]_NN ._. These_DT studies_NNS suggest_VBP RPE_NNP in_IN the_DT
          elderly_JJ are_VBP more_RBR susceptible_JJ to_TO oxidative_JJ stress_NN induced_VBD
          damage_NN ,_, which_WDT may_MD contribute_VB to_TO age-related_JJ RPE_NNP
          dysfunction_NN and_CC vision_NN loss_NN ._. The_DT oxidative_JJ stress_NN induced_VBD
          RPE_NNP cytotoxicity_NN can_MD be_VB aggravated_VBN by_IN zinc_NN deficiency_NN ,_, as_RB
          previously_RB reported_VBN by_IN Tate_NNP et_CC al_NN ._. [_NN 9_CD ]_NN ._.
          Significant_JJ morphological_JJ changes_NNS were_VBD observed_VBN in_IN RPE_NNP
          cells_NNS treated_VBN with_IN a_DT cytotoxic_JJ concentration_NN of_IN H_NNP 
          2_CD O_NNP 
          2_CD ._. Actin_NNP fiber_NN re-organization_JJ was_VBD
          noticed_VBN as_RB early_RB as_IN 15_CD minutes_NNS after_IN treatment_NN (_( Fig_NNP ._. 2_LS )_) ._.
          Those_DT images_NNS presented_VBN in_IN Fig_NNP ._. 2_LS D_NNP ,_, 2_CD Eand_NNP 2_CD Fare_VBP three_CD
          representatives_NNS of_IN RPE_NNP cells_NNS at_IN 4_CD hr_NN after_IN H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN ._. The_DT cells_NNS shown_VBN in_IN 2_CD D_NNP and_CC
          2_CD F_NN are_VBP commonly_RB seen_VBN at_IN different_JJ locations_NNS on_IN the_DT same_JJ
          slide_NN ._. In_IN Fig_NNP ._. 2_LS D_NNP ,_, the_DT dense_JJ peripheral_JJ bands_NNS of_IN actin_NN
          fibers_NNS were_VBD very_RB prominent_JJ in_IN some_DT cells_NNS and_CC the_DT high_JJ
          intensity_NN fluorescence_NN caused_VBD an_DT impression_NN that_IN the_DT
          cells_NNS were_VBD relatively_RB empty_JJ ._. The_DT thickening_VBG of_IN dense_JJ
          peripheral_JJ bands_NNS in_IN this_DT study_NN was_VBD in_IN contrast_NN to_TO
          previous_JJ observations_NNS in_IN endothelial_NN cells_NNS ._. For_IN example_NN ,_,
          Zhao_NNP and_CC Davis_NNP reported_VBD that_IN cultured_JJ pulmonary_JJ
          endothelial_NN cells_NNS treated_VBN with_IN H_NNP 
          2_CD O_NNP 
          2_CD underwent_VBD a_DT morphological_JJ change_NN
          that_WDT was_VBD accompanied_VBN by_IN an_DT accumulation_NN /_NN increase_NN in_IN
          stress_NN fibers_NNS running_VBG across_IN the_DT cells_NNS while_IN the_DT dense_JJ
          peripheral_JJ bands_NNS of_IN most_JJS cells_NNS were_VBD disrupted_VBN or_CC
          eliminated_VBN [_NN 38_CD ]_NN ._. Similar_JJ observations_NNS on_IN endothelial_NN
          cells_NNS were_VBD made_VBN by_IN Liu_NNP and_CC Sundqvist_NNP [_NN 39_CD ]_NN ._. The_DT dense_JJ
          peripheral_JJ bands_NNS are_VBP important_JJ in_IN cell-cell_JJ adhesion_NN ,_,
          which_WDT maintains_VBZ the_DT structural_JJ integrity_NN ._. While_IN it_PRP is_VBZ
          apparent_JJ that_IN endothelial_NN cells_NNS used_VBN in_IN those_DT studies_NNS and_CC
          epithelial_NN cells_NNS used_VBN in_IN this_DT study_NN respond_NN differently_RB
          to_TO H_NNP 
          2_CD O_NNP 
          2_CD ,_, the_DT underlying_VBG reason_NN for_IN this_DT
          difference_NN is_VBZ currently_RB unknown_JJ ._. One_PRP may_MD speculate_VB that_IN
          RPE_NNP cells_NNS use_VBP this_DT build-in_JJ mechanism_NN to_TO defend_VB the_DT
          oxidative_JJ stress_NN that_IN they_PRP are_VBP constantly_RB exposed_VBN to_TO ._. We_PRP
          currently_RB have_VBP no_DT data_NNS to_TO support_VB or_CC dismiss_VB this_DT
          possibility_NN ._. In_IN Fig_NNP ._. 2_LS E_NNP ,_, some_DT cultures_NNS responded_VBD to_TO H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN by_IN a_DT perinuclear_NN
          distribution_NN of_IN actin_NN fibers_NNS ._. In_IN Fig_NNP ._. 2_LS F_NN ,_, we_PRP observed_VBD
          microspikes_NNS at_IN the_DT periphery_NN of_IN the_DT cells_NNS ._. A_DT detailed_VBN
          study_NN of_IN microspikes_NNS by_IN Adams_NNP indicated_VBD that_IN these_DT
          structures_NNS consist_VBP of_IN actin_NN ,_, the_DT actin_NN binding_JJ protein_NN ,_,
          55_CD kd_NN /_NN fascin_NN and_CC myosin_NN [_NN 40_CD ]_NN ._. The_DT perinuclear_NN staining_VBG
          and_CC microspikes_NNS of_IN cells_NNS under_IN oxidative_JJ stress_NN in_IN this_DT
          study_NN are_VBP very_RB similar_JJ to_TO those_DT observed_VBN by_IN Huot_NNP et_CC al_NN ._.
          in_IN endothelial_NN cells_NNS treated_VBN with_IN H_NNP 
          2_CD O_NNP 
          2_CD [_NN 41_CD ]_NN ._. The_DT functional_JJ significance_NN
          of_IN these_DT structural_JJ changes_NNS in_IN RPE_NNP after_IN H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN is_VBZ not_RB clear_JJ ._. There_EX is_VBZ a_DT
          possibility_NN that_IN the_DT appearance_NN of_IN microspikes_NNS around_IN the_DT
          cells_NNS under_IN stressed_VBD conditions_NNS is_VBZ an_DT adapted_VBN behavior_NN of_IN
          the_DT cells_NNS in_IN order_NN to_TO attach_VB to_TO the_DT substratum_NN firmly_RB ._.
          Prolonged_NNP H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN led_VBN to_TO cell_NN death_NN with_IN the_DT
          appearance_NN of_IN condensed_JJ nuclei_NN is_VBZ an_DT indication_NN of_IN
          apoptosis_NNS (_( Fig_NNP ._. 4_LS C_NNP ,_, 4_CD D_NNP )_) ._. This_DT general_JJ finding_NN is_VBZ
          consistent_JJ with_IN that_DT observed_VBN by_IN others_NNS [_NN 8_CD 12_CD ]_NN ._.
          It_PRP is_VBZ of_IN interest_NN to_TO note_VB that_IN cultures_NNS with_IN a_DT reduced_VBN
          density_NN are_VBP more_RBR vulnerable_JJ to_TO H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN (_( Fig_NNP ._. 1_LS C_NNP )_) ._. One_CD
          straightforward_JJ explanation_NN for_IN the_DT vulnerability_NN of_IN
          low-density_NN cultures_NNS treated_VBN with_IN H_NNP 
          2_CD O_NNP 
          2_CD is_VBZ that_IN more_JJR molecules_NNS of_IN H_NNP 
          2_CD O_NNP 
          2_CD per_IN cell_NN were_VBD present_JJ in_IN these_DT
          low-density_NN cultures_NNS ,_, which_WDT caused_VBD a_DT lower_JJR viability_NN ._. If_IN
          this_DT were_VBD the_DT case_NN ,_, a_DT mathematic_JJ analysis_NN of_IN the_DT H_NNP 
          2_CD O_NNP 
          2_CD molecules_NNS per_IN cell_NN should_MD be_VB able_JJ to_TO
          estimate_VB the_DT cytotoxicity_NN in_IN this_DT experimental_JJ system_NN ._.
          For_IN example_NN ,_, 1_CD ._. 4_CD mM_NN H_NNP 
          2_CD O_NNP 
          2_CD in_IN a_DT culture_NN plated_JJ at_IN a_DT density_NN of_IN
          40_CD ,_, 000_CD cells_NNS /_NN well_RB should_MD result_VB in_IN a_DT viability_NN close_RB to_TO
          twice_RB of_IN that_DT generated_VBD in_IN 20_CD ,_, 000_CD cells_NNS /_NN well_RB and_CC four_CD
          times_NNS of_IN that_DT in_IN 10_CD ,_, 000_CD cells_NNS /_NN well_RB ._. Results_NNS from_IN Fig_NNP ._.
          1_LS Cindicated_NNP that_IN the_DT viability_NN of_IN each_DT condition_NN above_IN
          was_VBD 94_CD %_NN ,_, 49_CD %_NN or_CC 11_CD %_NN ,_, respectively_RB ._. It_PRP is_VBZ apparent_JJ that_IN H_NNP 
          2_CD O_NNP 
          2_CD killed_VBN more_JJR cells_NNS in_IN cultures_NNS of_IN
          lower_JJR density_NN (_( 10_CD ,_, 000_CD cells_NNS /_NN well_RB )_) than_IN expected_VBN ._. Because_IN
          the_DT result_NN could_MD not_RB always_RB be_VB predicted_VBN by_IN a_DT mathematic_JJ
          estimation_NN ,_, there_EX is_VBZ a_DT possibility_NN that_IN cell-cell_JJ
          contacts_NNS and_CC some_DT autocrine_NN /_NN paracrine_NN production_NN in_IN a_DT
          culture_NN may_MD alter_VB the_DT microenvironment_NN thus_RB determine_VB the_DT
          cytotoxicity_NN caused_VBN by_IN H_NNP 
          2_CD O_NNP 
          2_CD ._. Since_IN cells_NNS with_IN lower_JJR density_NN are_VBP
          more_RBR susceptible_JJ to_TO oxidative_JJ stress_NN ,_, there_EX is_VBZ a_DT
          possibility_NN that_IN a_DT vicious_JJ cycle_NN exists_VBZ such_JJ that_IN when_WRB an_DT
          area_NN of_IN RPE_NNP loses_VBZ some_DT of_IN the_DT constituent_NN cells_NNS by_IN
          oxidative_JJ stress_NN ,_, the_DT remaining_VBG cells_NNS will_MD become_VB even_RB
          more_RBR vulnerable_JJ to_TO this_DT insult_NN ._.
        
        
          PPARs_NNP in_IN RPE_NNP
          This_DT study_NN indicated_VBD that_IN the_DT PPARγ_NNP agonist_NN 15_CD d-_NN PGJ_NNP 
          2_CD could_MD prevent_VB H_NNP 
          2_CD O_NNP 
          2_CD induced_VBN RPE_NNP cell_NN death_NN (_( Figs_NNP ._.
          5_LS A_DT ,_, 5_CD Band_NNP Fig_NNP ._. 4_LS E_NNP )_) ._. This_DT suggests_VBZ that_IN this_DT agent_NN can_MD
          prevent_VB oxidative_JJ stress_NN induced_VBD RPE_NNP damage_NN ._. This_DT finding_VBG
          is_VBZ significant_JJ given_VBN prior_RB reports_VBZ that_IN oxidative_JJ stress_NN
          on_IN RPE_NNP is_VBZ an_DT important_JJ contributing_VBG factor_NN of_IN age-related_JJ
          macular_NN degeneration_NN [_NN 5_CD 42_CD ]_NN ._. An_DT earlier_JJR report_NN also_RB
          indicated_VBD that_IN PPARγ_NNP agonists_NNS could_MD prevent_VB laser_NN
          photocoagulation_NN induced_VBD choroidal_NN neovascularization_NN in_IN
          rat_NN eyes_NNS and_CC monkey_NN eyes_NNS ,_, which_WDT suggests_VBZ the_DT possible_JJ
          application_NN of_IN these_DT agents_NNS on_IN the_DT exudative_JJ form_NN of_IN
          age-related_JJ macular_NN degeneration_NN [_NN 43_CD ]_NN ._. It_PRP is_VBZ important_JJ
          to_TO note_VB that_IN the_DT other_JJ PPARγ_NNP agonists_NNS tested_VBN in_IN this_DT
          study_NN (_( ciglitazone_NN ,_, azelaoyl_NN PAF_NNP and_CC LY_NNP 171883_CD )_) were_VBD
          ineffective_JJ in_IN saving_VBG cells_NNS under_IN the_DT same_JJ experimental_JJ
          conditions_NNS ._. Since_IN three_CD out_IN of_IN four_CD PPARγ_NNP agonists_NNS tested_VBN
          were_VBD ineffective_JJ ,_, this_DT raises_VBZ the_DT possibility_NN that_IN the_DT
          saving_VBG effect_NN of_IN 15_CD d-_NN PGJ_NNP 
          2_CD is_VBZ not_RB through_IN PPARγ_NNP activation_NN ._. In_IN
          this_DT respect_NN ,_, it_PRP should_MD be_VB noted_VBN that_IN this_DT agent_NN has_VBZ been_VBN
          shown_VBN to_TO exert_VB some_DT biological_JJ effects_NNS that_WDT are_VBP
          independent_JJ of_IN PPARγ_NNP activation_NN [_NN 44_CD 45_CD 46_CD ]_NN ._.
          We_PRP have_VBP previously_RB shown_VBN that_IN 15_CD d-_NN PGJ_NNP 
          2_CD can_MD prevent_VB the_DT cytotoxicity_NN of_IN
          cholesterol_NN oxides_NNS ,_, end_NN products_NNS of_IN cholesterol_NN under_IN
          oxidative_JJ stress_NN [_NN 27_CD ]_NN ._. Together_RB with_IN results_NNS from_IN the_DT
          current_JJ study_NN ,_, this_DT agent_NN may_MD have_VB a_DT general_JJ protective_JJ
          effect_NN against_IN oxidative_JJ stress_NN itself_PRP or_CC against_IN
          cytotoxic_JJ agents_NNS generated_VBN by_IN oxidative_JJ stress_NN ._. It_PRP is_VBZ
          important_JJ to_TO note_VB that_IN 15_CD d-_NN PGJ_NNP 
          2_CD functions_NNS as_IN a_DT general_JJ inhibitor_NN of_IN
          immune_JJ activities_NNS ._. For_IN example_NN ,_, this_DT agent_NN is_VBZ a_DT potent_JJ
          inhibitor_NN of_IN microglia_NN ,_, the_DT macrophage-like_JJ cells_NNS in_IN the_DT
          central_JJ nervous_JJ system_NN [_NN 47_CD 48_CD 49_CD ]_NN and_CC shown_VBN to_TO be_VB
          effective_JJ in_IN reducing_VBG the_DT symptoms_NNS of_IN experimental_JJ
          autoimmune_JJ encephalomyelitis_NNS (_( EAE_NNP )_) ,_, an_DT animal_NN model_NN for_IN
          the_DT human_JJ disease_NN multiple_JJ sclerosis_NN [_NN 50_CD ]_NN ._. Together_RB ,_,
          these_DT results_NNS suggest_VBP that_IN this_DT agent_NN may_MD be_VB useful_JJ in_IN
          preventing_VBG ocular_NN diseases_NNS that_WDT result_NN from_IN oxidative_JJ
          stress_NN or_CC inflammation_NN ._.
        
        
          ERK_NNP activation_NN and_CC 4_CD -_: HNE_NNP protein_NN adducts_NNS formation_NN
          as_IN a_DT result_NN of_IN oxidative_JJ stress_NN
          Oxidative_NNP stress_NN is_VBZ a_DT potent_JJ stimulator_NN of_IN the_DT MAP_NNP
          kinase_NN activities_NNS [_NN 14_CD 15_CD 51_CD ]_NN ._. Phosphorylation_NNP of_IN ERK_NNP
          could_MD be_VB observed_VBN within_IN 30_CD -_: 60_CD minutes_NNS after_IN H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN (_( Fig_NNP ._. 6_CD )_) ._. There_EX are_VBP
          conflicting_JJ results_NNS in_IN literature_NN regarding_VBG whether_IN an_DT
          increase_NN of_IN ERK_NNP phosphorylation_NN is_VBZ beneficial_JJ or_CC
          detrimental_JJ to_TO cell_NN survival_NN ._. Bhat_NNP et_CC al_NN ._. demonstrated_VBN
          that_IN 5_CD -_: 25_CD μM_NN PD_NNP 98059_CD could_MD prevent_VB H_NNP 
          2_CD O_NNP 
          2_CD induced_VBN cell_NN death_NN in_IN an_DT
          oligodendrocyte_NN cell_NN line_NN [_NN 14_CD ]_NN ._. In_IN contrast_NN ,_, 20_CD μM_NN
          PD_NNP 98059_CD was_VBD shown_VBN to_TO enhance_VB cell_NN death_NN caused_VBN by_IN H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN in_IN HeLa_NNP cells_NNS [_NN 15_CD ]_NN ._.
          This_DT reagent_NN had_VBD no_DT significant_JJ effect_NN on_IN H_NNP 
          2_CD O_NNP 
          2_CD treated_VBN ARPE-_NNP 19_CD cells_NNS under_IN our_PRP$
          experimental_JJ conditions_NNS ._. AG_NNP 126_CD ,_, on_IN the_DT other_JJ hand_NN ,_,
          appeared_VBD to_TO reduce_VB the_DT cytotoxicity_NN caused_VBN by_IN oxidative_JJ
          stress_NN (_( Fig_NNP ._. 7_CD )_) ._. While_IN this_DT suggests_VBZ that_DT inhibition_NN of_IN
          tyrosine_NN phosphorylation_NN or_CC ERK_NNP activation_NN after_IN H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN might_MD be_VB beneficial_JJ for_IN
          the_DT cells_NNS ,_, results_NNS from_IN PD_NNP 98059_CD could_MD not_RB support_VB this_DT
          statement_NN ._.
          There_EX is_VBZ a_DT possibility_NN that_IN the_DT saving_VBG effect_NN of_IN AG_NNP 126_CD
          is_VBZ not_RB related_VBN to_TO ERK_NNP inhibition_NN ._. Under_IN the_DT current_JJ
          experimental_JJ conditions_NNS ,_, AG_NNP 126_CD at_IN 10_CD μM_NN was_VBD protective_JJ
          but_CC it_PRP enhanced_VBD H_NNP 
          2_CD O_NNP 
          2_CD toxicity_NN at_IN 20_CD μM_NN ._. These_DT results_NNS
          were_VBD consistent_JJ with_IN those_DT reported_VBN by_IN Sagara_NNP et_CC al_NN ._. [_NN 52_CD
          ]_NN ._. AG_NNP 126_CD belongs_VBZ to_TO a_DT group_NN of_IN tyrosine_NN kinase_NN
          inhibitors_NNS named_VBD tyrphostins_NNS ._. Many_JJ of_IN these_DT agents_NNS can_MD
          prevent_VB cellular_JJ oxidative_JJ stress_NN including_VBG that_WDT
          generated_VBN by_IN glutamate_NN ._. There_EX is_VBZ no_DT correlation_NN between_IN
          the_DT kinase_NN inhibition_NN and_CC the_DT observed_VBD protective_JJ effect_NN ._.
          Overnight_NNP treatment_NN of_IN cells_NNS with_IN AG_NNP 126_CD can_MD increase_VB
          cellular_JJ glutathione_NN levels_NNS ._. Furthermore_RB ,_, this_DT agent_NN has_VBZ
          some_DT anti-oxidant_JJ effect_NN based_VBN on_IN the_DT Trolox_NNP Equivalent_NNP
          Activity_NN Concentration_NNP [_NN 52_CD ]_NN ._. Collectively_RB ,_, this_DT may_MD
          explain_VB the_DT observation_NN that_IN AG_NNP 126_CD at_IN 10_CD μM_NN could_MD
          partially_RB prevent_VB H_NNP 
          2_CD O_NNP 
          2_CD induced_VBN cytotoxicity_NN ._. This_DT agent_NN can_MD
          also_RB function_VB as_IN a_DT mitochondria_NN uncoupler_NN ,_, thus_RB it_PRP
          actually_RB enhances_VBZ H_NNP 
          2_CD O_NNP 
          2_CD cytotoxicity_NN at_IN higher_JJR
          concentrations_NNS [_NN 52_CD ]_NN ._.
          An_DT accumulation_NN of_IN 4_CD -_: HNE-conjugated_NNP protein_NN has_VBZ been_VBN
          detected_VBN in_IN lesions_NNS of_IN aging-related_JJ diseases_NNS ,_, including_VBG
          Parkinson_NNP 's_POS disease_NN [_NN 53_CD ]_NN and_CC Alzheimer_NNP 's_POS disease_NN [_NN 54_CD ]_NN
          ._. It_PRP also_RB accumulates_NNS in_IN the_DT affected_VBN neuronal_NN tissues_NNS of_IN
          experimental_JJ animals_NNS experiencing_VBG brain_NN ischemia_NN [_NN 55_CD 56_CD
          ]_NN and_CC traumatic_JJ spinal_JJ cord_NN injury_NN [_NN 57_CD ]_NN ._. 4_CD -_: HNE_NNP can_MD
          impair_VB synaptosomal_NN membrane_NN proteins_NNS ,_, glutamate_NN
          transport_NN and_CC importantly_RB ,_, mitochondrial_NN functions_NNS [_NN 58_CD
          59_CD ]_NN ._. Evidence_NN indicates_VBZ that_IN 4_CD -_: HNE_NNP increases_NNS neuronal_NN
          susceptibility_NN to_TO oxidative_JJ stress_NN [_NN 60_CD ]_NN and_CC serves_VBZ as_IN a_DT
          mediator_NN of_IN oxidative_JJ stress_NN that_WDT leads_VBZ to_TO neuronal_NN
          apoptosis_NNS [_NN 61_CD ]_NN ._. As_IN indicated_VBD in_IN the_DT Introduction_NNP ,_,
          4_CD -_: HNE_NNP has_VBZ been_VBN implicated_VBN in_IN some_DT ocular_NN pathological_JJ
          conditions_NNS [_NN 19_CD 20_CD ]_NN ._.
          Several_JJ laboratories_NNS have_VBP attempted_VBN to_TO document_VB the_DT
          formation_NN of_IN 4_CD -_: HNE_NNP protein_NN adducts_NNS during_IN oxidative_JJ
          stress_NN by_IN Western_JJ blot_NN analysis_NN ._. Uchida_NNP et_CC al_NN ._. first_RB
          reported_VBD oxidative_JJ stress_NN caused_VBN by_IN t-butylhydroperoxide_JJ
          or_CC iron_NN /_NN ascorbate_NN could_MD lead_VB to_TO 4_CD -_: HNE_NNP protein_NN adducts_NNS in_IN
          hepatocytes_NNS [_NN 62_CD ]_NN ._. Further_RB studies_VBZ by_IN these_DT researchers_NNS
          attempted_VBD to_TO identify_VB the_DT common_JJ epitope_NN recognized_VBN by_IN
          the_DT 4_CD -_: HNE_NNP antibodies_NNS ._. However_RB ,_, no_DT specific_JJ protein_NN was_VBD
          positively_RB identified_VBN [_NN 63_CD ]_NN ._. More_RBR recently_RB ,_, the_DT
          formation_NN of_IN 4_CD -_: HNE_NNP protein_NN adducts_NNS was_VBD also_RB demonstrated_VBN
          by_IN Western_JJ blot_NN analysis_NN from_IN the_DT heart_NN [_NN 64_CD ]_NN ,_, the_DT
          liver_NN [_NN 65_CD ]_NN and_CC the_DT kidney_NN [_NN 66_CD ]_NN under_IN oxidative_JJ
          stress_NN ._. It_PRP is_VBZ important_JJ to_TO point_VB out_IN that_IN the_DT patterns_NNS of_IN
          4_CD -_: HNE_NNP protein_NN adducts_NNS ,_, as_IN shown_VBN by_IN these_DT Western_JJ blot_NN
          analyses_NNS ,_, were_VBD different_JJ among_IN these_DT studies_NNS ,_, probably_RB as_IN
          a_DT result_NN of_IN tissue_NN specificity_NN ._. No_DT particular_JJ protein_NN was_VBD
          identified_VBN as_IN a_DT specific_JJ target_NN for_IN 4_CD -_: HNE_NNP adduct_NN
          formation_NN in_IN these_DT studies_NNS ._. Results_NNS from_IN the_DT current_JJ
          study_NN indicate_VBP that_IN H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN of_IN RPE_NNP could_MD lead_VB to_TO the_DT
          accumulation_NN of_IN 4_CD -_: HNE_NNP protein_NN adducts_NNS in_IN the_DT cytoplasm_NN
          and_CC the_DT nuclei_NN of_IN these_DT cells_NNS (_( Fig_NNP ._. 3_LS )_) ._. There_EX was_VBD a_DT
          dose-dependent_JJ increase_NN of_IN 4_CD -_: HNE_NNP protein_NN adduct_NN after_IN H_NNP 
          2_CD O_NNP 
          2_CD treatment_NN with_IN a_DT maximal_NN intensity_NN
          of_IN ~_NN 7_CD X_NNP control_NN at_IN 2_CD mM_NN H_NNP 
          2_CD O_NNP 
          2_CD (_( Fig_NNP ._. 3_LS C_NNP )_) ._. This_DT may_MD partially_RB
          contribute_VB to_TO oxidative_JJ stress_NN induced_VBD ocular_NN disease_NN ._.
          Even_RB though_IN ocular_NN tissues_NNS ,_, including_VBG the_DT retina_NN ,_, contain_VB
          glutathione_NN S-_NNP transferases_NNS that_WDT can_MD actively_RB detoxify_NN
          4_CD -_: HNE_NNP [_NN 35_CD 67_CD ]_NN ,_, adverse_JJ events_NNS may_MD occur_VB if_IN aging_VBG or_CC
          pathological_JJ conditions_NNS hinder_VB this_DT normal_JJ defense_NN from_IN
          functioning_VBG properly_RB ._. It_PRP warrants_VBZ further_JJ studies_NNS to_TO
          identify_VB those_DT proteins_NNS species_NNS that_WDT are_VBP modified_VBN by_IN
          4_CD -_: HNE_NNP ._.
        
      
      
        Conclusions_NNP
        This_DT study_NN demonstrates_VBZ that_IN oxidative_JJ stress_NN induced_VBN by_IN
        H_NNP 
        2_CD O_NNP 
        2_CD could_MD lead_VB to_TO RPE_NNP cell_NN death_NN ,_, which_WDT is_VBZ
        preceded_VBN by_IN distinct_JJ morphological_JJ changes_NNS ,_, ERK_NNP activation_NN
        and_CC 4_CD -_: HNE_NNP protein_NN adduct_NN formation_NN ._. The_DT cell_NN death_NN can_MD be_VB
        prevented_VBN partially_RB by_IN AG_NNP 126_CD ,_, and_CC the_DT prostaglandin_NN
        derivative_JJ ,_, 15_CD d-_NN PGJ_NNP 
        2_CD ._. These_DT agents_NNS may_MD be_VB useful_JJ
        pharmacological_JJ tools_NNS in_IN the_DT future_JJ capable_JJ of_IN preventing_VBG
        oxidative_JJ stress_NN induced_VBD RPE_NNP cell_NN death_NN in_IN human_JJ ocular_NN
        diseases_NNS ._.
      
      
        Competing_VBG Interests_NNP
        None_NN declared_VBD ._.
      
      
        Authors_NNP '_'' Contributions_NNP
        TKG_NNP and_CC JYC_NNP were_VBD both_DT involved_VBN in_IN the_DT experimental_JJ
        design_NN and_CC data_NNS collection_NN ._. Both_DT authors_NNS read_VBP and_CC approved_VBD
        the_DT final_JJ manuscript_NN ._.
      
      
        Abbreviations_NNP
        15_CD d-_NN PGJ_NNP 
        2_CD ,_, 15_CD -_: deoxy-delta_JJ 12_CD ,_, 14_CD -_: Prostaglandin_NNP
        J_NNP 
        2_CD ;_: ERK_NNP ,_, Extracellular_NNP signal-_NN Regulated_NNP
        Kinase_NNP ;_: 4_CD -_: HNE_NNP ,_, 4_CD -_: hydroxynonenal_NN ,_, MAP_NNP kinases_NNS ,_,
        Mitogen-_NNP Activated_NNP Protein_NNP kinases_NNS ;_: MTT_NNP
        (_( 3_CD -_: (_( 4_CD ,_, 5_CD -_: dimethylthiazol-_NN 2_CD -_: yl_NN )_) -_: 2_CD ,_, 5_CD -_: diphenyltetrazolium_NN
        bromide_NN )_) ;_: PBS_NNP ,_, phosphate-buffered_JJ saline_NN ;_: PPARs_NNP ,_, peroxisome_NN
        proliferator-activated_JJ receptors_NNS ;_: RPE_NNP ,_, retinal_JJ pigment_NN
        epithelium_NN ._.
      
    
  
